- MindWalk Holdings Corp. (NASDAQ: HYFT) showcased its ReefIQ platform for AI drug discovery at AMD's Advancing AI 2026 event in San Francisco, marking its first public demonstration.
- The platform aims to bridge gaps in scattered biological data, enabling more effective AI reasoning by creating a unified context that enhances drug discovery processes.
- This demonstration highlights the ongoing competition in AI drug discovery, where companies are racing to establish the importance of integrated biological context versus merely improving model accuracy.
